Literature DB >> 7160447

Ganglioside changes during cell aging in human diploid fibroblast TIG-1.

T Ohsawa, Y Nagai.   

Abstract

Gangliosides of human diploid fibroblast, TIG-1, derived from fetal lung were analyzed during cell aging. The major gangliosides of TIG-1 cells were GM3 and GD3. During cell aging, GM3 and other gangliosides were decreased or below detection level. Lipid-bound sialic acid per mg protein was 2 micrograms at the early, middle and late passages, but between the middle and late passage it was twofold higher than the other passages.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160447     DOI: 10.1016/0531-5565(82)90018-3

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

1.  Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1.

Authors:  Tsutomu Kumazaki; Sayaka Kurata; Taira Matsuo; Youji Mitsui; Tomoko Takahashi
Journal:  Hum Cell       Date:  2011-05-12       Impact factor: 4.174

2.  Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging.

Authors:  Tomomi Tadokoro; Kiyotaka Yamamoto; Iku Kuwahara; Hirosuke Fujisawa; Masahiko Ikekita; Akiyoshi Taniguchi; Takeshi Sato; Kiyoshi Furukawa
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

3.  The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.

Authors:  J Müthing; J Peter-Katalinić; F G Hanisch; F Unland; J Lehmann
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

4.  Ganglioside alterations in YAC-1 cells cultivated in serum-supplemented and serum-free growth medium.

Authors:  J Müthing; A Pörtner; V Jäger
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

Review 5.  Vascular Diseases and Gangliosides.

Authors:  Norihiko Sasaki; Masashi Toyoda
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.